OA13042A - Process for preparing a polymorph of rosiglitazonemaleate. - Google Patents
Process for preparing a polymorph of rosiglitazonemaleate. Download PDFInfo
- Publication number
- OA13042A OA13042A OA1200500267A OA1200500267A OA13042A OA 13042 A OA13042 A OA 13042A OA 1200500267 A OA1200500267 A OA 1200500267A OA 1200500267 A OA1200500267 A OA 1200500267A OA 13042 A OA13042 A OA 13042A
- Authority
- OA
- OAPI
- Prior art keywords
- compound
- solvent
- maleate
- mixture
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0307259.2A GB0307259D0 (en) | 2003-03-28 | 2003-03-28 | Process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA13042A true OA13042A (en) | 2006-11-10 |
Family
ID=9955778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA1200500267A OA13042A (en) | 2003-03-28 | 2004-03-25 | Process for preparing a polymorph of rosiglitazonemaleate. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20070167494A1 (pt) |
| EP (1) | EP1615918A1 (pt) |
| JP (1) | JP2006521340A (pt) |
| KR (1) | KR20050120670A (pt) |
| CN (1) | CN1768057A (pt) |
| AU (2) | AU2004224068A1 (pt) |
| BR (1) | BRPI0408752A (pt) |
| CA (1) | CA2520249A1 (pt) |
| EA (1) | EA009331B1 (pt) |
| EC (1) | ECSP056038A (pt) |
| GB (1) | GB0307259D0 (pt) |
| IS (1) | IS8087A (pt) |
| MA (1) | MA27727A1 (pt) |
| MX (1) | MXPA05010413A (pt) |
| NO (1) | NO20054911L (pt) |
| OA (1) | OA13042A (pt) |
| WO (1) | WO2004085435A1 (pt) |
| ZA (1) | ZA200507100B (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020137940A1 (en) | 1997-12-16 | 2002-09-26 | Smithkline Beecham P.L.C. | 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical |
| US20040248945A1 (en) | 1999-04-23 | 2004-12-09 | Smithkline Beecham P.L.C. | Thiazolidinedione derivative and its use as antidiabetic |
| GB2405403A (en) * | 2003-08-29 | 2005-03-02 | Cipla Ltd | Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base |
| ITMI20041537A1 (it) * | 2004-07-28 | 2004-10-28 | Chemi Spa | Nuova forma polimorfa del rosiglitazone maleato |
| CZ298424B6 (cs) * | 2005-05-24 | 2007-09-26 | Zentiva, A. S. | Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel |
| EA201991780A1 (ru) | 2017-01-27 | 2021-10-26 | Нейрокрин Байосайенсиз, Инк. | Способы введения некоторых vmat2-ингибиторов |
| IL273300B2 (en) | 2017-09-21 | 2024-06-01 | Neurocrine Biosciences Inc | High dose valbenazine formulation and related preparations, methods and kits |
| JP2021502959A (ja) | 2017-10-10 | 2021-02-04 | ニューロクライン バイオサイエンシーズ，インコーポレイテッド | 特定のｖｍａｔ２インヒビターを投与するための方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
| GB9723295D0 (en) * | 1997-11-04 | 1998-01-07 | Smithkline Beecham Plc | Novel process |
| AP1598A (en) * | 1999-04-23 | 2006-04-26 | Smithkline Beecham Plc | Polymorph of 5-[4-[2-(N-methyl-N-(2-pyridyl) amino) ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt. |
| WO2000064893A2 (en) * | 1999-04-23 | 2000-11-02 | Smithkline Beecham Plc | Thiazolidinedione derivative and its use as antidiabetic |
| EP1173434B1 (en) * | 1999-04-23 | 2003-08-20 | SmithKline Beecham plc | Thiazolidinedione derivative and its use as antidiabetic |
| WO2002026737A1 (en) * | 2000-09-26 | 2002-04-04 | Dr. Reddy's Research Foundation | Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation |
-
2003
- 2003-03-28 GB GBGB0307259.2A patent/GB0307259D0/en not_active Ceased
-
2004
- 2004-03-25 CA CA002520249A patent/CA2520249A1/en not_active Abandoned
- 2004-03-25 EP EP04723254A patent/EP1615918A1/en not_active Withdrawn
- 2004-03-25 WO PCT/GB2004/001306 patent/WO2004085435A1/en active Application Filing
- 2004-03-25 JP JP2006506028A patent/JP2006521340A/ja not_active Withdrawn
- 2004-03-25 EA EA200501527A patent/EA009331B1/ru unknown
- 2004-03-25 CN CNA2004800083916A patent/CN1768057A/zh active Pending
- 2004-03-25 MX MXPA05010413A patent/MXPA05010413A/es unknown
- 2004-03-25 OA OA1200500267A patent/OA13042A/en unknown
- 2004-03-25 US US10/551,021 patent/US20070167494A1/en not_active Abandoned
- 2004-03-25 AU AU2004224068A patent/AU2004224068A1/en not_active Abandoned
- 2004-03-25 KR KR1020057018143A patent/KR20050120670A/ko not_active Application Discontinuation
- 2004-03-25 BR BRPI0408752-6A patent/BRPI0408752A/pt not_active IP Right Cessation
-
2005
- 2005-09-05 ZA ZA200507100A patent/ZA200507100B/en unknown
- 2005-09-26 EC EC2005006038A patent/ECSP056038A/es unknown
- 2005-10-11 MA MA28549A patent/MA27727A1/fr unknown
- 2005-10-24 IS IS8087A patent/IS8087A/is unknown
- 2005-10-24 NO NO20054911A patent/NO20054911L/no not_active Application Discontinuation
-
2008
- 2008-10-30 AU AU2008237610A patent/AU2008237610A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1615918A1 (en) | 2006-01-18 |
| CA2520249A1 (en) | 2004-10-07 |
| BRPI0408752A (pt) | 2006-03-28 |
| JP2006521340A (ja) | 2006-09-21 |
| MA27727A1 (fr) | 2006-01-02 |
| MXPA05010413A (es) | 2005-11-04 |
| ECSP056038A (es) | 2006-01-27 |
| CN1768057A (zh) | 2006-05-03 |
| EA200501527A1 (ru) | 2006-02-24 |
| NO20054911L (no) | 2005-10-24 |
| AU2004224068A1 (en) | 2004-10-07 |
| EA009331B1 (ru) | 2007-12-28 |
| AU2008237610A1 (en) | 2008-11-27 |
| WO2004085435A1 (en) | 2004-10-07 |
| GB0307259D0 (en) | 2003-05-07 |
| KR20050120670A (ko) | 2005-12-22 |
| IS8087A (is) | 2005-10-24 |
| ZA200507100B (en) | 2006-07-26 |
| US20070167494A1 (en) | 2007-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7655798B2 (en) | Process of making crystalline Type II aripiprazole | |
| US7538213B2 (en) | Methods for preparation of olanzapine polymorphic form I | |
| FR2900655A1 (fr) | Forme alpha du mesylate d'imatinib et procede de production de celui-ci | |
| AU2008237610A1 (en) | Process for preparing a polymorph of rosiglitazone maleate | |
| JPH04507085A (ja) | 置換イソフラボン誘導体の改良された製造方法 | |
| JP2008094848A (ja) | 新規な型の４−［４−［４−（ヒドロキシジフェニルメチル）−１−ピペリジニル］−１−ヒドロキシブチル］−α，α−ジメチルベンゼン酢酸及びその塩酸塩 | |
| WO2007109799A2 (en) | Polymorphs of eszopiclone malate | |
| WO2008084494A1 (en) | Novel polymorphic forms of carvedilol dihydrogen phosphate and process for preparing the same | |
| CA2453751A1 (en) | Purification and crystalline forms of zapelon | |
| AU2009336561A1 (en) | Stable R-(+)-lansoprazole amine salt and a process for preparing the same | |
| EP1858855B2 (en) | Process of making crystalline type ii aripiprazole | |
| EP2197273B1 (en) | Process for preparing r-gossypol l-phenylalaninol dienamine | |
| EP2242758B1 (en) | Crystalline form of abacavir that is essentially free of solvent | |
| KR102131107B1 (ko) | 3-아미노-피페리딘 화합물의 신규한 제조 방법 | |
| KR101125123B1 (ko) | 높은 광학적 순도의 ｓ-(-)-암로디핀을 제조하는 방법 및 그 중간생성 화합물 | |
| EP0531078B1 (en) | (R)-3-Methoxy-4- 1-methyl-5-(2-methyl-4,4,4-trifluorobutylcarbamoyl)indol-3-ylmethyl -N-(2-methylsulphonyl)benzamide in crystalline form | |
| KR20070088750A (ko) | 무수 아리피프라졸 제ｉｉ형의 제조 방법 | |
| US20060217408A1 (en) | Preparation of cabergoline | |
| HRP20030246A2 (en) | Crystal forms of 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazine hydrochloride | |
| JP4205130B2 (ja) | トレミフェン結晶化法 | |
| KR20220127965A (ko) | 리나글립틴의 안정한 결정형 b의 제조방법 | |
| CA2074058A1 (en) | Process to isolate carbacephem intermediates | |
| EP1140841A1 (fr) | Derives de 3-phenyl-2, 6-dioxopiperidin-3-yl propionamide et leur procede de preparation | |
| EP2109613A2 (en) | Polymorphs of eszopiclone malate |